Lipella Pharmaceuticals Inc. (LIPO)

OTCMKTS · Delayed Price · Currency is USD

0.1551

0.00 (0.00%)

At close: Feb 18, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pharmaceuticals	536.36K	449.62K	184.16K	259.35K	961.68K
Pharmaceuticals Growth	19.29%	144.15%	-28.99%	-73.03%	38.42%
Total	536.36K	449.62K	184.16K	259.35K	961.68K
Total Growth	19.29%	144.15%	-28.99%	-73.03%	38.42%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	536.36K	449.62K	184.16K	259.35K	961.68K
United States Growth	19.29%	144.15%	-28.99%	-73.03%	38.42%
Total	536.36K	449.62K	184.16K	259.35K	961.68K
Total Growth	19.29%	144.15%	-28.99%	-73.03%	38.42%

Source: S&P Global Market Intelligence.